View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB28 Publication ID: Fall 2010 
Title: Schedules of Controlled Substances: Exempted Prescription Product; River Edge Pharmaceutical, Servira  
Abstract: This Rule amends the list of Exempted Prescription Products found in section 1308.32 of title 21 of the Code of Federal Regulations. This action is in response to DEA's review of new applications for exemption. DEA has received one new application for exemption for River Edge Pharmaceutical's Servira®. Having reviewed this application and relevant information, DEA finds that this preparation has no significant potential for abuse. Therefore, DEA adds to the list of Exempted Prescription Products and exempted from the application of certain provisions of the Controlled Substances Act. 
Agency: Department of Justice(DOJ)  Priority: Routine and Frequent 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Final Rule Stage 
Major: No  Unfunded Mandates: No 
CFR Citation: 21 CFR 1308   
Legal Authority: 21 USC 811    21 USC 812    21 USC 871(b)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  03/30/2010  75 FR 15642   
NPRM Comment Period End  04/29/2010    
Final Action  12/00/2010    
Final Action Effective  01/00/2011    
Additional Information: DEA-335
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Information URL: www.dea.diversion.policy@usdoj.gov   Public Comment URL: www.regulations.gov  
RIN Data Printed in the FR: No 
Agency Contact:
Mark W. Caverly
Chief, Liaison and Policy Section
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7297
Email: dea.diversion.policy@usdoj.gov